BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng L, Du G. Illustrating human PLD. Nat Chem Biol 2020;16:364-5. [PMID: 32198491 DOI: 10.1038/s41589-020-0503-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Barriga HMG, Pence IJ, Holme MN, Doutch JJ, Penders J, Nele V, Thomas MR, Carroni M, Stevens MM. Coupling Lipid Nanoparticle Structure and Automated Single-Particle Composition Analysis to Design Phospholipase-Responsive Nanocarriers. Adv Mater 2022;:e2200839. [PMID: 35358374 DOI: 10.1002/adma.202200839] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cai M, Wang Z, Luu TTT, Zhang D, Finke B, He J, Tay LWR, Di Paolo G, Du G. PLD1 promotes reactive oxygen species production in vascular smooth muscle cells and injury-induced neointima formation. Biochim Biophys Acta Mol Cell Biol Lipids 2022;1867:159062. [PMID: 34610470 DOI: 10.1016/j.bbalip.2021.159062] [Reference Citation Analysis]
3 Zhang D, Du G. Phospholipid catabolism. Biochemistry of Lipids, Lipoproteins and Membranes 2021. [DOI: 10.1016/b978-0-12-824048-9.00008-0] [Reference Citation Analysis]
4 Meng F, Liang Z, Zhao K, Luo C. Drug design targeting active posttranslational modification protein isoforms. Med Res Rev 2021;41:1701-50. [PMID: 33355944 DOI: 10.1002/med.21774] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]